Identification and Validation of IFI44 as Key Biomarker in Lupus Nephritis.

biomarker hub genes lupus nephritis type-I interferon weighted gene co-expression network analysis

Journal

Frontiers in medicine
ISSN: 2296-858X
Titre abrégé: Front Med (Lausanne)
Pays: Switzerland
ID NLM: 101648047

Informations de publication

Date de publication:
2021
Historique:
received: 23 08 2021
accepted: 28 09 2021
entrez: 11 11 2021
pubmed: 12 11 2021
medline: 12 11 2021
Statut: epublish

Résumé

Lupus nephritis (LN) is a common and severe organ manifestation of systemic lupus erythematosus (SLE) and is a major cause of SLE related deaths. Early diagnosis is essential to improve the prognosis of patients with LN. To screen the potential biomarkers associated with LN, we downloaded the gene expression profile of GSE99967 from the Gene Expression Omnibus (GEO) database. Weighted gene co-expression network analysis (WGCNA) was utilized to construct a gene co-expression network and identify gene modules associated with LN. Gene Ontology (GO) analysis was also applied to explore the biological function of genes and identify the key module. Differentially expressed genes (DEGs) were identified and Maximal Clique Centrality (MCC) values were calculated to screen hub genes. Furthermore, we selected promising biomarkers for real-time PCR (qRT-PCR) and enzyme-linked immunosorbent assay (ELISA) validation in independent cohorts. Our results indicated that five hub genes, including IFI44, IFIT3, HERC5, RSAD2, and DDX60 play vital roles in the pathogenesis of LN. Importantly, IFI44 may considered as a key biomarker in LN for its diagnostic capabilities, which is also a promising therapeutic target in the future.

Identifiants

pubmed: 34760904
doi: 10.3389/fmed.2021.762848
pmc: PMC8574154
doi:

Types de publication

Journal Article

Langues

eng

Pagination

762848

Informations de copyright

Copyright © 2021 Shen, Lan, Zhu, Chen, Gu, Wang, Chen, Wang, Tu, Enghard, Jiang and Chen.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The reviewer JM declared a shared affiliation with the authors to the handling editor at time of review.

Références

J Immunol. 2012 Jul 15;189(2):988-1001
pubmed: 22723521
BMC Syst Biol. 2014;8 Suppl 4:S11
pubmed: 25521941
J Autoimmun. 2015 Jul;61:29-35
pubmed: 26005050
J Natl Med Assoc. 2020 Dec;112(6):567-577
pubmed: 32622555
EBioMedicine. 2017 Oct;24:267-276
pubmed: 28970079
Nat Rev Dis Primers. 2016 Jun 16;2:16039
pubmed: 27306639
DNA Cell Biol. 2019 Jul;38(7):639-650
pubmed: 31090450
Nature. 2021 Jan;589(7840):120-124
pubmed: 32937646
Nat Rev Nephrol. 2012 Jan 17;8(3):183-9
pubmed: 22249778
Viruses. 2021 Jun 09;13(6):
pubmed: 34207696
Gastroenterology. 2015 Feb;148(2):392-402.e13
pubmed: 25447848
Clin J Am Soc Nephrol. 2017 May 8;12(5):825-835
pubmed: 27821390
Front Genet. 2020 Dec 15;11:583629
pubmed: 33384713
Autoimmun Rev. 2019 Jul;18(7):733-737
pubmed: 31059847
Clin Immunol. 2017 Dec;185:32-39
pubmed: 27693588
Ann Rheum Dis. 2014 Jun;73(6):1052-9
pubmed: 23831963
J Autoimmun. 2013 Jun;43:78-84
pubmed: 23623029
Brief Bioinform. 2021 Jul 20;22(4):
pubmed: 33051665
Rheumatology (Oxford). 2016 Oct;55(10):1901-5
pubmed: 27354683
Front Immunol. 2021 May 17;12:668007
pubmed: 34079550
Bioengineered. 2021 Dec;12(1):2810-2819
pubmed: 34180358
J Am Soc Nephrol. 2007 Jun;18(6):1721-31
pubmed: 17460144
Eur J Immunol. 2008 Jul;38(7):1795-9
pubmed: 18581336
PLoS One. 2018 May 9;13(5):e0196117
pubmed: 29742110
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):3012-7
pubmed: 20133703
J Autoimmun. 2019 Jan;96:147-157
pubmed: 30301579
Curr Opin Immunol. 2020 Dec;67:87-94
pubmed: 33246136
Front Immunol. 2016 May 25;7:200
pubmed: 27252702
J Crohns Colitis. 2021 May 4;15(5):774-786
pubmed: 33232439
Arthritis Rheumatol. 2018 Dec;70(12):2036-2045
pubmed: 29806091
mBio. 2019 Aug 27;10(4):
pubmed: 31455651
Bioinformatics. 2007 Jul 15;23(14):1846-7
pubmed: 17496320
PeerJ. 2019 Oct 1;7:e7722
pubmed: 31592160
Nat Rev Dis Primers. 2020 Jan 23;6(1):7
pubmed: 31974366
Immunity. 2018 Mar 20;48(3):487-499.e5
pubmed: 29525521
J Autoimmun. 2018 Jul;91:97-102
pubmed: 29673738
BMC Bioinformatics. 2008 Dec 29;9:559
pubmed: 19114008
J Transl Med. 2021 Jan 19;19(1):35
pubmed: 33468161
Cell. 2016 Apr 21;165(3):551-65
pubmed: 27040498
Arthritis Res Ther. 2018 Jan 10;20(1):4
pubmed: 29321042
Mol Genet Genomic Med. 2021 Apr;9(4):e1648
pubmed: 33687153
J Am Soc Nephrol. 2013 Sep;24(9):1357-66
pubmed: 23929771
Am J Kidney Dis. 2020 Aug;76(2):265-281
pubmed: 32220510
Nat Rev Nephrol. 2015 Jun;11(6):329-41
pubmed: 25825084
Arthritis Rheumatol. 2016 Jun;68(6):1432-41
pubmed: 26815601

Auteurs

Lingling Shen (L)

Kidney Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
Key Laboratory of Nephropathy, Hangzhou, China.
Institute of Nephropathy, Zhejiang University, Hangzhou, China.
Zhejiang Clinical Research Center of Kidney and Urinary System Disease, Hangzhou, China.

Lan Lan (L)

Kidney Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
Key Laboratory of Nephropathy, Hangzhou, China.
Institute of Nephropathy, Zhejiang University, Hangzhou, China.
Zhejiang Clinical Research Center of Kidney and Urinary System Disease, Hangzhou, China.

Tingting Zhu (T)

Kidney Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
Key Laboratory of Nephropathy, Hangzhou, China.
Institute of Nephropathy, Zhejiang University, Hangzhou, China.
Zhejiang Clinical Research Center of Kidney and Urinary System Disease, Hangzhou, China.

Hongjun Chen (H)

Kidney Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
Key Laboratory of Nephropathy, Hangzhou, China.
Institute of Nephropathy, Zhejiang University, Hangzhou, China.
Zhejiang Clinical Research Center of Kidney and Urinary System Disease, Hangzhou, China.

Haifeng Gu (H)

Department of Geriatrics, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.

Cuili Wang (C)

Kidney Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
Key Laboratory of Nephropathy, Hangzhou, China.
Institute of Nephropathy, Zhejiang University, Hangzhou, China.
Zhejiang Clinical Research Center of Kidney and Urinary System Disease, Hangzhou, China.

Ying Chen (Y)

Kidney Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
Key Laboratory of Nephropathy, Hangzhou, China.
Institute of Nephropathy, Zhejiang University, Hangzhou, China.
Zhejiang Clinical Research Center of Kidney and Urinary System Disease, Hangzhou, China.

Minmin Wang (M)

Department of Nephrology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, China.

Haiyan Tu (H)

Department of Nephrology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Philipp Enghard (P)

Department of Nephrology and Medical Intensive Care, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Hong Jiang (H)

Kidney Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
Key Laboratory of Nephropathy, Hangzhou, China.
Institute of Nephropathy, Zhejiang University, Hangzhou, China.
Zhejiang Clinical Research Center of Kidney and Urinary System Disease, Hangzhou, China.

Jianghua Chen (J)

Kidney Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
Key Laboratory of Nephropathy, Hangzhou, China.
Institute of Nephropathy, Zhejiang University, Hangzhou, China.
Zhejiang Clinical Research Center of Kidney and Urinary System Disease, Hangzhou, China.

Classifications MeSH